Research and Development Department, TANTICA Biotechnology (Shanghai) Co., Ltd, Shanghai, China.
Department of Clinical Laboratory, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Biomarkers. 2024 Sep;29(6):343-351. doi: 10.1080/1354750X.2024.2373714. Epub 2024 Jul 23.
is hypermethylated in multiple cancers. also functions as a regulator of tumors. However, there are only very few reports on the association of methylation of and with lung cancer (LC) in peripheral blood.
426 LC patients and 428 age- and sex-matched healthy controls were recruited. DNA methylation in blood was semi-quantitively assessed by mass spectrometry. For the association analysis, binary logistic regression analysis adjusted covariant was applied, and ORs were presented as per +10% methylation.
Hypermethylation of CpG_1, CpG_5 and CpG_8 in was significantly associated with LC (ORs = 1.45, 1.35 and 1.35, respectively, adjusted < 0.05), and even stage I LC. The association between the three CpG sites and LC was enhanced by increased age (> 55 years, ORs ranged from 1.43 to 1.75, adjusted < 0.05), male gender (ORs ranged from 1.47 to 1.59, adjusted < 0.05) and tumor stage (stage II&III&IV, ORs ranged from 1.86 to 3.03, adjusted < 0.05).
This study suggests a significant association between blood-based hypermethylation and LC, especially in elder people, in males and in LC patients with advanced stage.
在多种癌症中呈超甲基化状态。同时也作为肿瘤的调节剂。然而,关于血液中甲基化与肺癌(LC)的关联,仅有极少数报道。
招募了 426 名 LC 患者和 428 名年龄和性别匹配的健康对照者。通过质谱法对半定量评估血液中的 DNA 甲基化。对于关联分析,应用了调整协变量的二元逻辑回归分析,并以每 +10%甲基化的 OR 呈现。
CpG_1、CpG_5 和 CpG_8 中 的超甲基化与 LC(ORs=1.45、1.35 和 1.35,分别为调整后 <0.05)显著相关,甚至在 I 期 LC 中也是如此。这三个 CpG 位点与 LC 之间的关联随着年龄的增加(>55 岁,OR 范围从 1.43 到 1.75,调整后 <0.05)、男性性别(OR 范围从 1.47 到 1.59,调整后 <0.05)和肿瘤分期(II&III&IV 期,OR 范围从 1.86 到 3.03,调整后 <0.05)而增强。
本研究表明血液中 高甲基化与 LC 之间存在显著关联,尤其是在老年人、男性和晚期 LC 患者中。